Answer
Rybrevant (amivantamab) is contraindicated in patients with hypersensitivity to amivantamab or any of its excipients listed in section 6.1.
Sources for this answer
- Rybrevant (amivantamab) 350mg concentrate for solution for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 11Document updated
Sources checked